New drug aims to shrink hard-to-treat tumors in 30-patient trial
NCT ID NCT06365840
First seen Apr 18, 2026 · Last updated Apr 30, 2026 · Updated 2 times
Summary
This study tests an experimental drug called IMC-001 in 30 adults whose advanced solid tumors have a high number of genetic mutations (TMB-H). The main goal is to see if the drug can shrink tumors. Researchers will also monitor side effects and how long the drug keeps the cancer from growing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TMB-H are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Cancer Center
RECRUITINGGoyang, South Korea
Contact
-
Samsung Medical Center
RECRUITINGSeoul, South Korea
Contact
-
Seoul National University Bundang Hospital
RECRUITINGSeongnam, South Korea
Contact
-
Severance Hospital
RECRUITINGSeoul, South Korea
Contact
Conditions
Explore the condition pages connected to this study.